Attached files
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
TCR2 Therapeutics Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading Experts in the prospectus.
(signed) KPMG LLP
Cambridge, Massachusetts
December 28, 2018